Research News and Research

RSS

Researchers link air pollution to cerebral atrophy but find no impact on cognitive function

Exposure to mid- to high-range PM2.5 is linked to cerebral atrophy, but there is no significant impact on cognitive function. The findings suggest that urbanization plays a role in modulating the effects of air pollution on brain structure.

6 Oct 2024

Pasteurization effectively reduces H5N1 virus in milk but further testing is essential

Research explores the resilience of the H5N1 influenza virus in milk under pasteurization conditions, showing effective viral inactivation at standard temperatures but highlighting the need for further real-world testing.

6 Oct 2024

How carnitine transporters boost reproductive health

Research uncovers the critical role of carnitine transporters in maintaining fertility by regulating energy metabolism and protecting reproductive cells from oxidative stress. It suggests new pathways for treating infertility through carnitine supplementation and targeted therapies.

6 Oct 2024

Schizophrenia-related hallucinations linked to disrupted motor-sensory signals

Researchers identified that impaired corollary discharge (CD) and noisy efference copy (EC) in schizophrenia disrupt self-monitoring, leading to auditory hallucinations. A computational model revealed how these motor-to-sensory dysfunctions contribute to hallucinations.

6 Oct 2024

Study reveals high effectiveness of flu vaccines in children but highlights challenges with certain subtypes

Study found that influenza vaccination is highly effective in preventing infection and hospitalization in children, though efficacy against certain subtypes like H3N2 remains limited due to small sample sizes.

6 Oct 2024

Park runs boost life satisfaction and save money by improving well-being

Park runs improve life satisfaction, especially for the least active, while providing significant economic benefits through cost-effectiveness.

6 Oct 2024

CheekAge: Next-gen epigenetic clock accurately predicts mortality risk

Researchers developed CheekAge, an epigenetic clock based on buccal cells, and found it predicted mortality risk with significant accuracy. This study validates CheekAge as a reliable aging biomarker, outperforming first-generation clocks.

6 Oct 2024

Study reveals bias in substance use screening for injured adolescents

Injured adolescents from marginalized groups treated at pediatric trauma centers are more likely to be tested for drugs and alcohol than white adolescents, even when accounting for injury severity, a study led by researchers at UCLA and Children's Hospital Los Angeles suggests.

4 Oct 2024

Researchers reveal mechanisms of how CDK12 alterations drive prostate cancer development

When researchers at the University of Michigan Rogel Cancer Center first identified a new subtype of aggressive prostate cancer, they knew they needed to understand how this genetic alteration was driving cancer and how to target it with treatment.

4 Oct 2024

New framework established for defining prebiotics

The concept of prebiotics – defined as substrates that are selectively utilized by host microorganisms conferring a health benefit – was introduced in the scientific community nearly 30 years ago.

4 Oct 2024

Jefferson Lab team explores proton therapy as a safer cancer treatment

Radiation therapy techniques have been used for more than a century to treat cancers. Physicists in the Radiation Detector and Imaging group and associated with the Biomedical Research & Innovation Center (BRIC) at the U.S. Department of Energy's Thomas Jefferson National Accelerator Facility have been for several years pursuing radiation therapy technology improvements in collaboration with the Hampton University Proton Cancer Institute (HUPCI).

4 Oct 2024

Women who inject drugs are vulnerable to endocarditis, study shows

People who inject drugs are dying at an alarming rate from endocarditis, a serious but treatable heart-valve infection.

4 Oct 2024

Global experts gather in Brisbane for scientific meeting dedicated to influenza

More than 1,400 experts have visited Brisbane for the world's only scientific meeting dedicated to influenza.

4 Oct 2024

Exploring the venomous potential of marine crustaceans for drug development

Many animals use venoms for self-defense or hunting. The components of such venom, known as toxins, interfere with various physiological processes - which is also the reason why they are so interesting for the development of new pharmacological agents.

4 Oct 2024

AI revolutionizes ophthalmology with oculomics for cardiovascular risk assessment

A recent position paper in the Asia-Pacific Journal of Ophthalmology explores the transformative potential of artificial intelligence (AI) in ophthalmology.

4 Oct 2024

Engineered E. coli shows promise in cancer immunotherapy

Recent research has shown that certain forms of E. coli bacteria tend to colonize hypoxic areas of the body, including tumors, suggesting they might be playing a role in cancer therapeutics.

4 Oct 2024

Collaborative study investigates underlying cause of neuropsychiatric symptoms in Parkinson's disease

Parkinson's disease is most known for its movement-related symptoms: tremors and rigidity, slowness and falls, caused by the loss of the brain's dopamine-producing neurons.

4 Oct 2024

New analysis raises concerns over Medicare Advantage spending for veterans

From 2011 to 2020, the Veterans Health Administration spent $78 billion to care for U.S. military veterans enrolled in Medicare Advantage plans, raising questions about federal overpayments to those private plans.

4 Oct 2024

Study identifies a new target for developing atrial fibrillation therapy

A new study by researchers at the University of Arizona College of Medicine – Phoenix and the University of California Davis Health identified a new target for developing a therapy to treat atrial fibrillation, the most common type of abnormal heart rhythm.

4 Oct 2024